For the past decade, digital health has been heralded as the next disrupter in the delivery of care, but the reality is that, globally, there has been minimal uptake in widespread adoption. While the technology has made great strides to enable digital health, providers, payers, and consumers have been slower to adopt than was anticipated, in part due to slow regulatory approvals and the lack of an adequate reimbursement model. Having said that, the COVID-19 pandemic has been a catalyst in advancing some digital health solutions, specifically in remote patient care.
Building on this momentum and to facilitate the acceleration of digital health, APACMed is organizing the inaugural edition of their Digital Health Symposium.
It aims to bring together international and regional leaders to share learnings around use cases that have succeeded and discuss how Asia can accelerate the implementation of digital health solutions. Speakers will share valuable insights on reimbursement models and challenges to successful remote care management implementations to deliver better patient outcomes.
Be inspired by an expert line-up of speakers and panelists including TedxHHL speaker, Farina Schurzfeld, Stanley Li, CEO of DXY, amongst other movers and shakers in the Medtech industry.
Be part of the conversation on a hot topic: Remote Care Management and Reimbursement where you get real life, practical insights through no-hold-barred, honest discussions.
Contribute to the collective voice in influencing digital health policy formulation through dialogues with policymakers and payers in Asia.
Lessons learned from German digital health care model from an ecosystem perspective from founders and industry shapers.
Deep dive on China digital health platforms to understand their journeys in establishing presence in remote care management.
Leading industry case examples and reflections of the current challenges and path forward for MedTech.
With the current global healthcare crisis causing unprecedented demands on our healthcare services and the way in which we carry out our daily lives, there is an opportunity for digital health solutions to support healthcare providers and the way we continue to provide care for patients. Could coronavirus be the catalyst to widespread digital uptake for healthcare?
Welcome by APACMed (5 mins)
Opening by MOHT (10 mins)
Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. In this panel discussion, we outline the reimbursement and monetization use cases of remote patient monitoring in Germany, and discuss implementation challenges, lessons and opportunities.
Fireside Chat: Remote care management in Germany
Q&A (10 mins)
As a result of the pandemic, there has been a rapid acceleration of wide-spread adoption of digital technology in the delivery of healthcare services such as remote patient monitoring and telemedicine in China. The panel will deep dive into China’s digital health platforms to share their journeys in establishing presence in remote care management.
Self intro (5 mins)
Panel discussion of remote care models and patient management in China (30 mins)
Q&A (10 mins)
The rapid development of digital health present immense opportunities for access, clinical outcome and efficiency improvements across Asia. The panel will cover examples of leading industry case examples and reflections of current challenges and learnings to pave the way forward for medical technology in Asia.
Quick fire presentation of use cases and challenges (20 mins)
Panel discussion of learnings and path forward for RCM (25 mins)
Closing the symposium
Farina is a social entrepreneur, advisor and speaker. In 2017 she founded Selfapy – Germanys leading therapy platform for people suffering from mental health disorders. As a growth expert, she lived in Sydney where she became part of the founding team of the discount portal Groupon. Later she started Airtasker, a platform for mini jobs, which is now listed on the ASX where she led the (international) expansion. During that time, she also founded Sydney’s largest Co-Working Space TSL, which counts more than 400 members today. In 2017, Farina has been awarded as “Top 30 under 30” of Forbes Magazine as well as one of the “25 women, that make the world more sustainable”.
Tiantian Li (Stanley Li), Founder and Chairman of DXY
Mr. Li earned his master’s degree in tumor immunology at Harbin Medical University and gave up his Ph.D. in neuromuscular disease research. He has been recognized as a leading player in the Internet health industry due to his insight and contribution. Mr. Li is also a visiting professor at Harbin Medical University, vice president of the health promotion commission in Zhe Jiang Province.
DXY (Ding Xiang Yuan)
Founded in 2000, DXY has become a leading digital service provider in the healthcare industry of China. DXY has built the largest and most active online community for professional users such as physicians, nurses, and pharmacists. It launched a series of web and mobile-based educational materials and tools to facilitate HCPs to learn evidence-based knowledge and improve clinical skills. Currently, DXY has covered over two million Chinese doctors, 70% of total doctors in China. DXY launched the first COVID-19 dashboard globally, cited by JHU, WHO, CDC, Lancet, and acquired 5 billion visitings.
Since 2015, DXY has launched the “DX-Doctor” with products and services targeting health and wellness. DX-Doctor has become the most well-known and trusted brand to the massive population in China. DX-Doctor provides data-driven online/offline products and services to fulfill consumer’s demands for a healthy lifestyle. In five years, DX-Doctor has touched over 130 million consumers. During the COVID-19 pandemic, DX-Doctor has created over 3,600 articles and video clips to fight the infodemic, which acquired 4 billion visitings.
Global entrepreneurial leader with more than 30 years of experience in advanced medical imaging, computer assisted diagnosis, large-scale healthcare IT transformation and clinical informatics. Wido Menhardt is experienced in leading workforces of 2000+ engineers and innovators in the field of enterprise imaging and clinical informatics. During his past tenures at e.g. Philips and Beckman Coulter (Danaher) he powered global healthcare IT and informatics solution businesses with $500 - $700+M revenue impact, respectively. Along his CDS (clinical decision support) focused career path, his broad area of expertise bridged fields such as strategy and evangelism for digital transformation of healthcare, the transition to cloud deployment, introduction of large-scale IoT platforms, development and deployment of operational analytics solutions, and the development of value propositions for mobile solutions across global product and solution portfolios. Currently Wido Menhardt is serving as Executive Vice President Digital Health at Siemens Healthineers. His global employee base supports and automates clinical decisions along the patient journey, driving efficiency, quality and standardization. He is also driving the entrepreneurial digital transformation of 52,000+ Siemens Healthineers.
Dr. Robert JT Morris is Professor, National University of Singapore Yong Loo Lin School of Medicine and Chief Technology Strategist for the Ministry of Health Transformation (MOHT). He is also an Advisor to the National Research Foundation in the Prime Minister’s Office. His current focus is on application of computer and information sciences, including AI, to transform healthcare.
From 2011-2017, he led all IBM Research’s Global Laboratories, and built new laboratories in Brazil, Australia, Africa and Singapore. IBM Research earned 6 Nobel prizes, laying the basis for the information revolution. In 2010 Fortune and Money Magazine declared Robert the “Smartest Scientist in Technology” in their print magazines and on the web https://ibm.biz/BdrbY4.
During 2006-2011, Robert was VP Services Research, IBM TJ Watson Research Center, NY, helping start IBM’s healthcare and IoT businesses, and earlier VP Assets Innovation, IBM Global Services. From 1999-2004, he was the VP & Director of IBM Almaden Research Center, Silicon Valley, where relational database technology, the disk drive, etc., were invented. Responsible for creation of Services Science, research for IBM’s ThinkPad, and Storage Systems. Earlier he led advanced systems research at TJ Watson Center, including the Deep Blue chess machine, which defeated world champion Garry Kasparov in 1997. Originally from Australia, he began his career at Bell Labs working on early neural networks and the largest packet switch of the era (2STP).
Robert was Chairman, Bay Area Science and Innovation Consortium (BASIC) 2001-2005, comprising heads of major research institutions in Silicon Valley. Published over 60 scientific articles, awarded 11 patents. Editor IEEE Trans. on Computers and on many boards. Received the Australian-American Fulbright and Gowrie Fellowships, PICMET Leadership in Tech. Mgmt. Award, Fellow IEEE, IBM Acad. of Technology, Government University Industry Research Roundtable (National Academies).
Shehaan Fernando is the Regional Director for Connected Care Informatics at Philips. He is passionate about changing the trajectory of health expenditure and improving patient outcomes through value-based care initiatives. In his role he helps partners build virtual care capability both operationally and clinically, bringing a new paradigm to healthcare where better patient outcomes are achieved with fewer resources closer to home.
Sheri Dodd has over 25 years of healthcare experience spanning the pharmaceutical, medical device and public health sector.
Ms. Dodd is the Vice President and General Manager for the Medtronic Care Management Services business and for the Non-Intensive Diabetes Therapies Business.
Medtronic Care Management Services (MCMS) includes patient monitoring and care management services focused on improving clinical and economic outcomes for the complex, chronic, comorbid patient. Non-Intensive Diabetes Therapies (NDT) focuses on patients with type 2 diabetes with the goal of making glucose a vital sign.
Ms. Dodd joined Medtronic in March 2010 and has served in clinical, health economics & reimbursement leadership roles. Prior to Medtronic, she spent 13 years at Johnson & Johnson and 5 years at the World Health Organization. She holds a Masters degree in Health Planning and Financing from the London School of Economics.
Volker E. Amelung was born in 1965. He studied Business Administration at the Universities of St. Gallen and Paris-Dauphine.
In 2001 Volker Amelung has been appointed professor at the Medical University of Hannover with focus on health management and international health services research.
Since 2007 Volker Amelung is also the president of the German Managed Care Association (BMC), Berlin
In 2011 he founded the private institute for applied health research (inav) in Berlin.
Geoff Kau is currently Co-President of Ping An Smart City, focusing on Healthcare, Education, Environment and Agriculture technology businesses.
Mr. Kau has spearheaded the development of Ping An’s AI-dreven HealthTech efforts since 2017, which now serves over 50 city governments and 20,000 medical institutions. Before joining Smart City, Mr. Kau was Deputy GM of Ping An Technology where he helped incubate Ping An’s FinTech arm, OneConnect, now listed on NYSE, and led the Group‘s AI+financial services efforts.
Mr. Kau is formerly a consultant with McKinsey & Company, where he served over ten of the world’s largest financial institutions and technology companies.
Florian Then is a Partner based at McKinsey & Company’s Shanghai office. He is a core member of our Healthcare Practice in Asia and leading McKinsey’s work with Medtech clients in the region.
Florian has 2 decades of healthcare experience as a physician, scientist, and strategy consultant. He has been with McKinsey for 13 years.
Florian has deep experience serving Medtech clients across a wide range of topics:
▪ Organic and inorganic growth strategies for domestic Greater China and other Asian markets
▪ Business model innovation including new go to market models, distribution channel models, and digital / telehealth initiatives
▪ Organizational transformation, commercial capability building and leadership capability building
▪ M&A related work (commercial due diligences, post merger integration)
Florian is also working with distributors, hospitals and health insurance companies in Asia. He has deep expertise across relevant trends in the healthcare ecosystem and related to China’s healthcare reform
Before joining McKinsey, Florian worked as a physician and neuroscientist
▪ He graduated as an MD from Ludwig Maximillians University ( LMU ) in Munich where he also completed his PhD studies in tumor immunology
▪ After doing clinical work in Munich, Boston, and Nanjing, Florian received a research grant to pursue postdoctoral studies in Neuroscience at Massachusetts General Hospital, Harvard Medical School, in Boston (Mass General Institute for Neurodegenerative Diseases MIND)
Andrew Frye is senior vice president and president, APAC, for Baxter Healthcare and is the current Chairman of the Board of Directors for APACMed.
Andrew joined Baxter in 2017 from DKSH Holdings Ltd., where he served as Global Head of Healthcare from 2015 to 2017. In that role, he oversaw a portfolio of pharmaceuticals, over-the-counter and device products across 13 countries. Previously, he served as vice president of Business Development from 2011 to 2014 for DKSH Healthcare. Earlier in his career, he held a number of commercial roles with increasing responsibility at Abbott Laboratories’ Pharmaceutical and Nutrition divisions.
Andrew received a bachelor’s degree in psychobiology from the University of Southern California and master’s degree in marketing from the Anderson School of Management at the University of California. He resides with his family in Singapore.
Harjit was appointed CEO of APACMed in February 2019. Founded in 2014, the Asia Pacific Medical Technology Association is the only regional association to provide a unified voice for the medical technology industry in Asia Pacific.
She was formerly EVP and CEO of Philips ASEAN & Pacific until October 2015. In this role, she managed a team of 10,000 people in 10 countries across its Healthcare, Lighting and Consumer Lifestyle sectors. Harjit spent over two decades with Philips holding a variety of international roles in General Management in England, Holland, Singapore, Dubai and Hong Kong.
Passionate about innovation and healthcare reform, she holds concurrent positions on several prestigious boards:
• Board Member, ResMed, a pioneer in cloud connected, innovative solutions, for people with sleep apnea, COPD, and other chronic respiratory diseases
• Board Member, MAS Holdings, South East Asia’s largest manufacturer of apparel and textiles
• Board Member, Apollo Education, a leading English Education provider in Vietnam
• Advisor, Delmedica, an innovative Singapore-based company that has developed the X-Halo, the world’s first breath thermometer for managing respiratory diseases.
She is a former Singapore Chapter Chair of the Young Presidents Organisation, the premier leadership organisation of Chief Executives in the world, and former Board member of the SICC, National University of Singapore Entrepreneurship Committee and World Economic Forum Global Agenda Council on South East Asia. Harjit has spoken at several global leadership platforms including the World Economic Forum, INSEAD and IMC on Innovation and Healthcare.
BROUGHT TO YOU BY